ArticleObesity surgery2022

SGLT2 Inhibition with Empagliflozin as a Possible Therapeutic Option for Postprandial Hypoglycemia After Bariatric Surgery.

Giovanna B Carpentieri et al.PubMed ↗Publisher ↗

No numbers read from the abstract.